Tygacil has strengthened its warning label. The new Tygacil warning tells doctors and patients that alternatives to Tygacil should be considered in treating serious infections due to Tygacil’s increased risk of mortality, in comparison with other antibiotics in treating infections.
Tygacil (science name: tigecycline) is an antibiotic that fights bacteria in the body. Tygacil is used to fight a variety of different bacterial infections than the digestive system and infections of the skin. Doctors also use Tygacil to fight pneumonia.
The increased mortality risk was most prevalent in those being treated for hospital-acquired pneumonia, for which Tygacil is not FDA approved. Tygacil is FDA approved for the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired pneumonia.
Not for nothing, this drug was “fast-tracked” to approval six years ago. I’m always skeptical of any medication that was fast-tracked.